HLA incompatible combined liver-kidney transplantation: Dynamics of antibody modulation revealed by a novel approach to HLA antibody characterisation

Transplant Immunology

Volumn 30, Issue 1, 2014, Pages 30-33

  Lowe, David ^a   Shabir, Shazia ^b   Buckels, John ^b   Muiesan, Paolo ^b   Hayden, Geoffrey ^b   Holt, Andrew ^b   Hamsho, Ahmed ^b   Skordilis, Kassi ^b   Lipkin, Graham ^b   Borrows, Richard ^b   Briggs, David ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Combined liver kidney transplantation; Crossmatching; Epitope; HLA specific antibody

Indexed keywords

BASILIXIMAB; EPITOPE; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; ALLOANTIBODY; HLA ANTIGEN;

ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; GRAFT FAILURE; HISTOINCOMPATIBILITY; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PATHOGENICITY; PRIORITY JOURNAL; ACUTE DISEASE; ANTIBODY PRODUCTION; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNIZATION; IMMUNOLOGY; METABOLISM; POLYCYSTIC KIDNEY DISEASES; PROCEDURES; SEROLOGY;

ACUTE DISEASE; ADULT; ANTIBODY FORMATION; EPITOPES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOMODULATION; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POLYCYSTIC KIDNEY DISEASES; SEROLOGIC TESTS;

EID: 84891831024     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.11.002     Document Type: Article

References (17)

1. Ingelsten M., Karlsson-Parra A., Granqvist A.B., Molne J., Olausson M., Haraldsson B., et al. Postischemic inflammatory response in an auxiliary liver graft predicts renal graft outcome in sensitized patients. Transplantation 2011, 91(8):888-894.
2. Olausson M., Mjornstedt L., Norden G., Rydberg L., Molne J., Backman L., et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007, 7(1):130-136.
3. Key T., Watson C., Clatworthy M., O'Rourke C., Goodman R., Taylor C., et al. The kinetics of donor HLA class I-specific antibody absorption following a combined split liver and kidney transplant 2010, NDT Plus.
4. Fung J., Makowka L., Tzakis A., Klintmalm G., Duqeusnoy R., Gordon R., et al. Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988, 20(1 Suppl. 1):88-91.
5. Lobo P., Spencer C., Douglas M., Stevenson W., Pruett T. The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation 1993, 55(5):1063-1066.
6. Higgins R.M., Bevan D.J. Antibody removal therapy in transplantation. Transplant Rev 1995, 9(4):177-199.
7. Duquesnoy R.J., Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 2002, 63(5):353-363.
8. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002, 63(5):339-352.
9. Duquesnoy R.J., Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007, 68(1):12-25.
10. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67(11):847-862.
11. El-Awar N., Lee J., Tarsitani C., Terasaki P. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007, 68(3):170-180.
12. El-Awar N., Akaza T., Terasaki P., Nguyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007, 84(4):532-540.
13. Lowe D., Hathaway M., Briggs D. The high-dose hook effect in the detection and monitoring of HLA specific antibody by Luminex assay. Int J Immunogenet 2007, 34:288.
14. Higgins R., Lowe D., Hathaway M., Lam F., Kashi H., Tan L., et al. Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. Transplantation 2009, 87(6):882-888.
15. Higgins R., Lowe D., Hathaway M., Williams C., Lam F., Kashi H., et al. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch. Transplantation 2011, 92(8):900-906.
16. Nair V., Sawinski D., Akalin E., Friedlander R., Ebcioglu Z., Sehgal V., et al. Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates. Clin Transplant 2012, 26(3):E261-E268.
17. Higgins R., Hathaway M., Lowe D., Lam F., Kashi H., Tan L., et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007, 84(7):876-884.